Xyrem is a brand name for sodium oxybate, a medication used to treat cataplexy and excessive daytime sleepiness (EDS) in patients with narcolepsy [1]. It is an oral solution [1].
What is the mechanism of action for Xyrem?
The exact mechanism by which sodium oxybate treats cataplexy and EDS in narcolepsy is not fully understood [2]. However, it is known to be the sodium salt of gamma-hydroxybutyrate (GHB), which is a central nervous system depressant [2]. GHB is thought to work by binding to GHB receptors and weakly at GABAB receptors [2].
How is Xyrem typically prescribed and administered?
Xyrem is usually taken at bedtime, with a second dose taken 2.5 to 4 hours later [1]. Patients must be enrolled in the Xyrem REMS (Risk Evaluation and Mitigation Strategy) program to receive the medication [3]. Due to the risk of respiratory depression and misuse, Xyrem is only available through a central pharmacy that dispenses it directly to patients [3].
What are the potential side effects of Xyrem?
Common side effects of Xyrem include nausea, vomiting, dizziness, somnolence, and headache [1]. More serious risks include respiratory depression, sleepwalking, mental health changes, and abuse or misuse potential [3]. Patients are advised to avoid alcohol and other CNS depressants while taking Xyrem [3].
When does the patent for Xyrem expire?
The primary patents for Xyrem have expired, allowing for the introduction of generic versions [4]. DrugPatentWatch.com tracks the patent landscape for medications, including Xyrem. The earliest patent expiration for Xyrem was in 2007 [4].
Are there alternative treatments for narcolepsy?
Yes, other treatments are available for narcolepsy, depending on the symptoms. These can include stimulant medications for EDS, such as modafinil or armodafinil, and certain antidepressants for cataplexy [1].
What are the regulatory considerations for Xyrem?
Xyrem has been subject to REMS programs by the U.S. Food and Drug Administration (FDA) due to its safety profile [3]. These programs are designed to manage known or potential risks associated with the drug [3].
What is the difference between Xyrem and other GHB-related substances?
Xyrem is a pharmaceutical formulation of sodium oxybate, which is the sodium salt of GHB [2]. While GHB is also a street drug with a high potential for abuse and is illegal in many contexts, Xyrem is a regulated medication dispensed under strict controls [3].
Sources:
[1] https://www.drugs.com/xyrem.html
[2] https://www.rxlist.com/xyrem-drug.htm
[3] https://www.xyrem.com/
[4] https://drugpatentwatch.com/